Table 1.

Baseline characteristics of included patients undergoing VALS

Variables	POP patients (n = 106)
Age, mean ± SD, years	55.86 ± 8.48
BMI, mean ± SD, kg/m²	24.10 ± 2.89
Gravidity, median (range)	3 (1–8)
Parity, median (range)	2 (1–6)
Menopause status, n (%)	76 (71.7)
Comorbidity, n (%)
Hypertension	18 (16.98)
Diabetes	5 (4.72)
Coronary heart disease	3 (2.83)
Hyperthyroidism	2 (1.89)
Hypothyroidism	2 (1.89)
Hysteromyoma	26 (24.53)
Stress urinary incontinence	23 (21.70)
Urgent urinary incontinence	3 (2.83)
Mixed urinary incontinence	2 (1.89)
Depression	2 (1.89)
Previous surgery history, n (%)
Tubal ligation	18 (16.98)
Cesarean delivery	4 (3.77)
Hysteromyomectomy	2 (1.89)
Pelvic reconstruction surgery	4 (3.77)
Vaginal repair	3 (2.83)
POP-Q stage, n (%)
III	59 (55.66)
IV	47 (44.34)
Follow-up period, median (range), months	35.40 (12.13–109.97)

VALS Vaginally assisted laparoscopic sacrocolpopexy; POP Pelvic organ prolapse; BMI Body mass index; SD Standard deviation